Effect of the third dose of BNT162b2 vaccine on quantitative SARS-CoV-2 spike 1–2 IgG antibody titers in healthcare personnel

ME Romero-Ibarguengoitia, D Rivera-Salinas… - PLoS …, 2022 - journals.plos.org
Background Vaccination is our main strategy to control SARS-CoV-2 infection. Given the
decrease in quantitative SARS-CoV-2 spike 1–2 IgG antibody titers three months after the …

Chemosensory ability and sensitivity in health and disease: epigenetic regulation and COVID-19

N Bhatia-Dey, AB Csoka, T Heinbockel - International Journal of …, 2023 - mdpi.com
Throughout the animal kingdom, our two chemical senses, olfaction and gustation, are
defined by two primary factors: genomic architecture of the organisms and their living …

Analysis of immunization time, amplitude, and adverse events of seven different vaccines against SARS-CoV-2 across four different countries

ME Romero-Ibarguengoitia, A González-Cantú… - Frontiers in …, 2022 - frontiersin.org
Background Scarce information exists in relation to the comparison of seroconversion and
adverse events following immunization (AEFI) with different SARS-CoV-2 vaccines. Our aim …

Efficacy of six different SARS-coV-2 vaccines during a six-month follow-up and five COVID-19 waves in Brazil and Mexico

ME Romero-Ibarguengoitia, D Rivera-Salinas, R Sarti… - Vaccines, 2023 - mdpi.com
Comparisons among the different vaccines against SARS-CoV-2 are important to
understand which type of vaccine provides more protection. This study aimed to evaluate the …

Mucosal antibody response and SARS‐CoV‐2 shedding in patients with COVID‐19 related olfactory dysfunction

S Sharma, A Thiriard, V Olislagers… - Journal of medical …, 2024 - Wiley Online Library
Olfactory dysfunction (OD) was one of the most common symptom of infection with the
Wuhan strain of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and could …

Effectiveness of different booster vaccine combinations against SARS-CoV-2 during a six-month follow-up in Mexico and Argentina

A Garza-Silva, D Rivera-Salinas… - Frontiers in …, 2024 - frontiersin.org
Introduction Given the limited number of patients in Latin America who have received a
booster dose against the COVID-19, it remains crucial to comprehend the effectiveness of …

Persistence of neutralizing antibodies to sars-cov-2 in first wave infected individuals at ten months post-infection: the UnIRSA cohort study

G Griffante, S Chandel, D Ferrante, V Caneparo… - Viruses, 2021 - mdpi.com
Longitudinal mapping of antibody-based SARS-CoV-2 immunity is critical for public health
control of the pandemic and vaccine development. We performed a longitudinal analysis of …

Characterization of IgG Antibody Response against SARS-CoV-2 (COVID-19) in the Cypriot Population

G Krashias, E Deeba, A Constantinou, M Hadjiagapiou… - Microorganisms, 2021 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has hit its
second year and continues to damage lives and livelihoods across the globe. There …

Analyzing the diffusion and duration of antibodies to SARS-CoV-2 during the natural infection and comparison with vaccination

C Pozzi, E Azzolini, M Rescigno - The European Physical Journal Plus, 2023 - Springer
To monitor SARS-CoV-2 diffusion, we measured anti-Spike S1/S2 IgGs in the serum of
nearly 4000 workers employed in several healthcare facilities for one year. We found that …

SARS-CoV-2-specific antibody (Ab) levels and the kinetic of ab decline determine ab persistence over 1 year

E Garner-Spitzer, A Wagner, M Kundi… - Frontiers in …, 2022 - frontiersin.org
In a SARS-CoV-2 seroprevalence study conducted with 1,655 working adults in spring of
2020, 12 of the subjects presented with positive neutralization test (NT) titers (> 1: 10). They …